Drug Development

Our work is driven by a strong scientific understanding of disease and awareness of unmet medical needs.

In this section

Drug Development
Novartis Global Drug Development (GDD) delivers successful innovations to improve patients’ lives. We lead the industry in R&D investment and in the number of approvals from regulatory bodies, and are recognized and respected for the quality of our work.
Our Process
Our R&D strategy is driven by innovative science and guided by patient needs.
Clinical Pipeline
Novartis has one of the industry's most respected development pipelines with more than 200 products in clinical development.
Focus on Patient Outcomes
We invest in the development of new technologies that improve patient adherence and help predict individual response to treatment.
Research Disease Areas
Novartis has a longstanding commitment to understanding the underlying molecular basis of disease.

Quick Links

Our Work
Access to Healthcare
Our Work
Innovation in Healthcare
Drug Development
Drug Development
About Us
Corporate Responsibility
CAREERS

We build an exciting and collaborative workplace where people can realize their professional ambitions

Read More